MicroRNAs in Osteosarcoma: Diagnostic and Therapeutic Aspects

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2013 Jun 26

PMID 23797816

Citations 81

Authors

Jinglei Miao

Song Wu

Zhi Peng

Mousumi Tania

Chaoyue Zhang

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are small RNA molecules, which can interfere with the expression of several genes and act as gene regulator. miRNAs have been proved as a successful diagnostic and therapeutic tool in several cancers. In this review, the differential expression of miRNAs in osteosarcoma and their possibility to be used as diagnostic and therapeutic tools have been discussed. Osteosarcoma is the most common primary bone tumor that mainly affects children and adolescents. The current treatment of osteosarcoma remains difficult, and osteosarcoma causes many deaths because of its complex pathogenesis and resistance to conventional treatments. Several studies demonstrated that the differential expression patterns of miRNAs are a promising tool for the diagnosis and treatment of osteosarcoma. Although some aspect of the mechanism of action of miRNAs in controlling osteosarcoma has been identified (e.g., targeting the Notch signaling pathway), it is far beyond to the clear understanding of miRNA targets in osteosarcoma. Identification of the specific target of miRNAs may aid molecular targets for drug development and future relief of osteosarcoma.

Citing Articles

MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements.

Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos M, Galian J Biomedicines. 2024; 12(1).

PMID: 38255221 PMC: 10813128. DOI: 10.3390/biomedicines12010116.

Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p.

Yang D, Chen Y, He Z, Wang Y, Ke C, Luo Y Front Pharmacol. 2023; 14:1194094.

PMID: 37284323 PMC: 10239870. DOI: 10.3389/fphar.2023.1194094.

Exosomes and osteosarcoma drug resistance.

Fu H, Wu Y, Chen J, Hu X, Wang X, Xu G Front Oncol. 2023; 13:1133726.

PMID: 37007086 PMC: 10064327. DOI: 10.3389/fonc.2023.1133726.

MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease.

Smout D, Van Craenenbroeck A, Jorgensen H, Evenepoel P Clin Kidney J. 2023; 16(3):408-421.

PMID: 36865016 PMC: 9972833. DOI: 10.1093/ckj/sfac219.

Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis.

Shao Z, Bi S Front Endocrinol (Lausanne). 2023; 13:1100063.

PMID: 36714568 PMC: 9880040. DOI: 10.3389/fendo.2022.1100063.

References

Osuna D, de Alava E . Molecular pathology of sarcomas. Rev Recent Clin Trials. 2009; 4(1):12-26. DOI: 10.2174/157488709787047585. View

Admassi D . Osteosarcoma of medial cuniform bone. Ethiop Med J. 2010; 47(4):305-8. View

Calvert G, Randall R, Jones K, Cannon-Albright L, Lessnick S, Schiffman J . At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma. 2012; 2012:152382. PMC: 3329649. DOI: 10.1155/2012/152382. View

Sarver A, Thayanithy V, Scott M, Cleton-Jansen A, Hogendoorn P, Modiano J . MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma. Orphanet J Rare Dis. 2013; 8:7. PMC: 3566973. DOI: 10.1186/1750-1172-8-7. View

Liu L, Li H, Li J, Zhong H, Zhang H, Chen J . miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Biochem Biophys Res Commun. 2011; 416(1-2):31-8. DOI: 10.1016/j.bbrc.2011.10.117. View

Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A . Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer. 2010; 129(3):680-90. DOI: 10.1002/ijc.25715. View

Sassen S, Miska E, Caldas C . MicroRNA: implications for cancer. Virchows Arch. 2007; 452(1):1-10. PMC: 2151131. DOI: 10.1007/s00428-007-0532-2. View

Zhang W, Qian J, Yi H, Yang Z, Wang C, Chen J . The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression. Mol Biol (Mosk). 2012; 46(4):622-7. View

Park S, Lee J, Ha M, Nam J, Kim V . miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2008; 16(1):23-9. DOI: 10.1038/nsmb.1533. View

10.

Heneghan H, Miller N, Kerin M . MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol. 2010; 10(5):543-50. DOI: 10.1016/j.coph.2010.05.010. View

11.

Martin J, Squire J, Zielenska M . The genetics of osteosarcoma. Sarcoma. 2012; 2012:627254. PMC: 3364016. DOI: 10.1155/2012/627254. View

12.

Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q . MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One. 2012; 7(3):e33778. PMC: 3310405. DOI: 10.1371/journal.pone.0033778. View

13.

Mraz M, Pospisilova S . MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back. Expert Rev Hematol. 2012; 5(6):579-81. DOI: 10.1586/ehm.12.54. View

14.

Sakamoto A, Iwamoto Y . Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy. Rev Recent Clin Trials. 2008; 3(3):228-31. PMC: 2778092. DOI: 10.2174/157488708785700267. View

15.

Di Fiore R, Fanale D, Drago-Ferrante R, Chiaradonna F, Giuliano M, De Blasio A . Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. J Cell Physiol. 2012; 228(6):1189-201. DOI: 10.1002/jcp.24272. View

16.

Wu X, Zhong D, Gao Q, Zhai W, Ding Z, Wu J . MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression. Int J Med Sci. 2013; 10(6):676-82. PMC: 3619116. DOI: 10.7150/ijms.5528. View

17.

Kobayashi E, Hornicek F, Duan Z . MicroRNA Involvement in Osteosarcoma. Sarcoma. 2012; 2012:359739. PMC: 3329862. DOI: 10.1155/2012/359739. View

18.

Cantley L, Neel B . New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A. 1999; 96(8):4240-5. PMC: 33561. DOI: 10.1073/pnas.96.8.4240. View

19.

Hu H, Zhang Y, Cai X, Huang J, Cai L . Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. Oncol Lett. 2012; 4(5):1037-1042. PMC: 3499612. DOI: 10.3892/ol.2012.866. View

20.

Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H . MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 2011; 10(8):1337-45. PMC: 3711153. DOI: 10.1158/1535-7163.MCT-11-0096. View